Deutsche Bank Ag\ Ac Immune Sa Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Ac Immune Sa stock. As of the latest transaction made, Deutsche Bank Ag\ holds 253,375 shares of ACIU stock, worth $684,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,375

Previous 253,375 -0.0%

Holding current value

$684,112

Previous $1.01 Million 5.25%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.13 - $2.49 $12,993 - $15,189	-6,100 Reduced 2.35%	253,375 $592,000
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.12 $42,256 - $76,652	-24,568 Reduced 8.65%	259,475 $529,000
Q1 2022 May 13, 2022	BUY	$3.5 - $5.16 $85,988 - $126,770	24,568 Added 9.47%	284,043 $1.14 Million
Q4 2021 Feb 11, 2022	BUY	$4.83 - $7.56 $1.25 Million - $1.95 Million	258,000 Added 17491.53%	259,475 $1.28 Million
Q3 2021 Nov 04, 2021	SELL	$6.2 - $8.34 $496,000 - $667,200	-80,000 Reduced 98.19%	1,475 $10,000
Q2 2021 Aug 11, 2021	BUY	$6.04 - $8.37 $190,109 - $263,445	31,475 Added 62.95%	81,475 $646,000
Q1 2021 May 13, 2021	SELL	$5.32 - $8.96 $292,600 - $492,800	-55,000 Reduced 52.38%	50,000 $380,000
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $80,951 - $101,053	18,110 Added 20.84%	105,000 $543,000
Q3 2020 Nov 12, 2020	BUY	$4.78 - $9.06 $29,420 - $55,764	6,155 Added 7.62%	86,890 $424,000
Q2 2020 Aug 13, 2020	BUY	$6.57 - $8.3 $523,740 - $661,651	79,717 Added 7830.75%	80,735 $543,000
Q1 2020 May 14, 2020	SELL	$4.24 - $9.89 $14,937 - $34,842	-3,523 Reduced 77.58%	1,018 $7,000
Q4 2019 Feb 14, 2020	SELL	$4.56 - $8.78 $25,061 - $48,254	-5,496 Reduced 54.76%	4,541 $38,000
Q3 2019 Nov 14, 2019	SELL	$4.8 - $5.89 $77,174 - $94,699	-16,078 Reduced 61.57%	10,037 $49,000
Q2 2019 Aug 14, 2019	SELL	$4.72 - $5.88 $315,517 - $393,060	-66,847 Reduced 71.91%	26,115 $144,000
Q1 2019 May 15, 2019	BUY	$3.65 - $11.68 $339,311 - $1.09 Million	92,962 New	92,962 $468,000
Q4 2018 Feb 14, 2019	SELL	$7.35 - $11.7 $154,350 - $245,699	-21,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $69,706 - $145,516	8,846 Added 72.78%	21,000 $168,000
Q2 2018 Aug 14, 2018	SELL	$8.17 - $10.9 $381,302 - $508,713	-46,671 Reduced 79.34%	12,154 $113,000
Q1 2018 May 15, 2018	BUY	$10.34 - $13.78 $571,915 - $762,185	55,311 Added 1574.02%	58,825 $608,000
Q3 2017 Nov 14, 2017	BUY	$7.06 - $11.2 $24,808 - $39,356	3,514	3,514 $39,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $225M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account